Evidence map›Paper›PMID 39156221›Full record

ArticleInorganica chimica acta2024

Metal complexes of backbone-halogenated imidazol-2-ylidenes.

Alejandro Bugarin, Siddappa A Patil, Ryan Q Tran, Kostiantyn O Marichev

Abstract read
In one paragraph

Article in Inorganica chimica acta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The Chemistry of Dinuclear SilverCoordination chemistry reviews · 2025
    Article
  2. The Chemistry of Polynuclear SilverCoordination chemistry reviews · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alejandro BugarinDepartment of Chemistry and Physics, Florida Gulf Coast University, Fort Myers, FL, USA.
Siddappa A PatilCentre for Nano and Material Sciences, Jain (Deemed-to-be University), Jain Global Campus, Kanakapura, Bangalore, Karnataka, India.
Ryan Q TranDepartment of Chemistry, Georgia State University, Atlanta, GA, USA.
Kostiantyn O MarichevDepartment of Chemistry, Georgia State University, Atlanta, GA, USA.

Funding

Assessing Ligand vs Ligandless Catalysis to Simplify Chemical Transformations and Drug DiscoveryR15GM141726 · NIGMS · FLORIDA GULF COAST UNIVERSITY · PI BUGARIN, ALEJANDRO · 2021 to 2021
$397k
NIGMS NIH HHS R15 GM141726
6 · The paper itself

Abstract

In this manuscript, literature reports on mono- and di-halogen (F, Cl, Br, and I) substituted at positions 4 or/and 4,5 imidazol-2-ylidene (NHC) metal complexes are discussed: particularly, their structural diversity with various metals (groups 6-13), important physicochemical properties, catalytic and medicinal/biological applications are reviewed. To our knowledge, there are no literature reports on group 4 and 5 metal complexes with this type of NHC ligands. Halogenated imidazol-2-ylidene metal complexes deserve special attention because halogens are the classic electron donating groups (mesomerically) in conjugated aromatic/heteroaromatic ring systems, but electron withdrawing inductively. However, they exhibit a significant electron withdrawing inductive effect, thus providing unique electronic properties. This is important for fine tuning of σ-donor abilities of the "carbenic" carbon of imidazol-2-ylidenes, which directly affect catalytic performance of their metal complexes. Other applications, advantages, and disadvantages of halogenated vs. unsubstituted imidazol-2-ylidene metal complexes are critically analyzed and summarized in this review.

Indexed as

biological activitiescatalysishalogenated NHCsmetal complexesN-Heterocyclic carbenesstructural analysis

Identifiers

PMID39156221
PMCPMC11326507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.